Acquired resistance in cancer refers to the phenomenon where initially responsive cancer cells develop resistance to therapeutic agents over time. This resistance can emerge after an initial period where the cancer responds well to treatment but eventually adapts to evade the effects of the drugs. This adaptive mechanism poses a significant challenge in cancer therapy, often leading to treatment failure and disease progression.
